Chemoinformaics analysis of 12-Acetoxycaryophyllene-4,5-epoxide
| Molecular Weight | 280.408 | nRot | 2 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 15 |
| Exact Molecular Weight | 280.204 | nRing | 3 |
| Solubility: LogS | -4.607 | nHRing | 1 |
| Solubility: LogP | 4.216 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 49.4662 |
| nHD | 0 | BPOL | 32.4298 |
| QED | 0.573 |
| Synth | 4.628 |
| Natural Product Likeliness | 2.996 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.86 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.786 |
| MDCK | 0.0000234 |
| BBB | 0.613 |
| PPB | 0.899075 |
| VDSS | 1.46 |
| FU | 0.117299 |
| CYP1A2-inh | 0.082 |
| CYP1A2-sub | 0.214 |
| CYP2c19-inh | 0.102 |
| CYP2c19-sub | 0.895 |
| CYP2c9-inh | 0.224 |
| CYP2c9-sub | 0.143 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.692 |
| CYP3a4-inh | 0.121 |
| CYP3a4-sub | 0.366 |
| CL | 10.957 |
| T12 | 0.15 |
| hERG | 0.026 |
| Ames | 0.045 |
| ROA | 0.027 |
| SkinSen | 0.824 |
| Carcinogencity | 0.104 |
| EI | 0.085 |
| Respiratory | 0.661 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.613613 |